subscribeSubscribe
Health Canada approves new indication for Merck’s Prevymis

Health Canada approves new indication for Merck’s Prevymis
PHARMABIZ
22 Apr 2024
Share Share
Merck Receives Positive EU CHMP Opinion for PREVYMIS

Merck Receives Positive EU CHMP Opinion for PREVYMIS
BUSINESSWIRE
17 Oct 2023
Share Share
Merck`s CMV drug is approved for kidney transplant patients

Merck`s CMV drug is approved for kidney transplant patients
Katherine Lewin ENDPTS
07 Jun 2023
Share Share
U.S. FDA Approves New Indication for Merck’s PREVYMIS for Prevention of CMV

U.S. FDA Approves New Indication for Merck’s PREVYMIS for Prevention of CMV
BUSINESSWIRE
06 Jun 2023
Share Share
U.S. FDA Accepts for Priority Review the Supplemental NDA for Merck’s PREVYMIS

U.S. FDA Accepts for Priority Review the Supplemental NDA for Merck’s PREVYMIS
BUSINESSWIRE
17 Feb 2023
Share Share
Merck`s Prevymis outdoes Roche`s Valcyte in toxicity measure

Merck`s Prevymis outdoes Roche`s Valcyte in toxicity measure
Kevin Dunleavy FIERCEPHARMA
25 Oct 2022
Share Share
NICE recommendation for MSD’s Prevymis after re-evaluation

NICE recommendation for MSD’s Prevymis after re-evaluation
Anna Smith PharmaTimes
03 Jun 2019
Share Share
Merck antiviral drug Prevymis wins NICE over

Merck antiviral drug Prevymis wins NICE over
Kyle Blankenship FIERCE PHARMA
30 May 2019
Share Share
Prescription med: registration of new chemical entities in Australia

Prescription med: registration of new chemical entities in Australia
TGA
09 Jul 2018
Share Share
Merck Sharp & Dohme`s Prevymis (letermovir) Receives Approval In Europe

Merck Sharp & Dohme`s Prevymis (letermovir) Receives Approval In Europe
EMA
19 Jan 2018
Share Share